Nolan Priedigkeit, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Estrogen Receptor alpha | 6 | 2022 | 578 | 0.680 |
Why?
|
Breast Neoplasms | 16 | 2022 | 21056 | 0.590 |
Why?
|
Gene Expression Regulation, Neoplastic | 8 | 2021 | 8611 | 0.460 |
Why?
|
Estrogens | 1 | 2021 | 1529 | 0.440 |
Why?
|
Hirschsprung Disease | 1 | 2015 | 164 | 0.420 |
Why?
|
Receptor, erbB-2 | 2 | 2022 | 2593 | 0.360 |
Why?
|
Sequence Analysis, RNA | 2 | 2017 | 2034 | 0.340 |
Why?
|
Bone Neoplasms | 2 | 2022 | 2567 | 0.320 |
Why?
|
Evolution, Molecular | 2 | 2015 | 1889 | 0.320 |
Why?
|
Calcinosis | 1 | 2017 | 1479 | 0.310 |
Why?
|
Mutation | 8 | 2022 | 30198 | 0.280 |
Why?
|
Gene Regulatory Networks | 1 | 2015 | 1748 | 0.260 |
Why?
|
Brain Neoplasms | 3 | 2020 | 9071 | 0.200 |
Why?
|
Nuclear Receptor Coactivator 3 | 1 | 2021 | 45 | 0.180 |
Why?
|
Inflammatory Breast Neoplasms | 1 | 2022 | 150 | 0.180 |
Why?
|
Gene Expression Profiling | 6 | 2021 | 9525 | 0.170 |
Why?
|
DNA Copy Number Variations | 3 | 2021 | 2045 | 0.170 |
Why?
|
Cadherins | 2 | 2021 | 900 | 0.160 |
Why?
|
Biomimetic Materials | 1 | 2020 | 170 | 0.160 |
Why?
|
ADAM Proteins | 1 | 2020 | 242 | 0.160 |
Why?
|
Cyclin-Dependent Kinase Inhibitor Proteins | 1 | 2018 | 53 | 0.160 |
Why?
|
Receptors, Angiotensin | 1 | 2017 | 141 | 0.140 |
Why?
|
Neoplastic Cells, Circulating | 2 | 2022 | 950 | 0.140 |
Why?
|
Receptor, Angiotensin, Type 1 | 1 | 2017 | 153 | 0.140 |
Why?
|
Genes, erbB-2 | 1 | 2017 | 160 | 0.140 |
Why?
|
Allyl Compounds | 1 | 2016 | 23 | 0.130 |
Why?
|
CARD Signaling Adaptor Proteins | 1 | 2017 | 164 | 0.130 |
Why?
|
Carcinoma, Lobular | 1 | 2020 | 471 | 0.130 |
Why?
|
Histone Deacetylases | 1 | 2021 | 708 | 0.130 |
Why?
|
Melanoma | 1 | 2015 | 5719 | 0.130 |
Why?
|
Retinal Dehydrogenase | 1 | 2016 | 78 | 0.130 |
Why?
|
Mutant Chimeric Proteins | 1 | 2015 | 19 | 0.130 |
Why?
|
Computational Biology | 2 | 2021 | 3559 | 0.130 |
Why?
|
Gene Amplification | 2 | 2018 | 1091 | 0.130 |
Why?
|
Karyopherins | 1 | 2016 | 134 | 0.130 |
Why?
|
Cyclin-Dependent Kinase 6 | 1 | 2018 | 352 | 0.120 |
Why?
|
Sulfides | 1 | 2016 | 165 | 0.120 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2018 | 561 | 0.120 |
Why?
|
Neoplasms, Second Primary | 1 | 2022 | 1050 | 0.110 |
Why?
|
Drug Resistance, Neoplasm | 3 | 2018 | 5337 | 0.110 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2020 | 1083 | 0.110 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 2022 | 1833 | 0.100 |
Why?
|
Gene Fusion | 1 | 2015 | 357 | 0.100 |
Why?
|
DNA, Neoplasm | 2 | 2018 | 1742 | 0.100 |
Why?
|
Aromatase | 1 | 2012 | 147 | 0.100 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2016 | 852 | 0.100 |
Why?
|
Chromosomes | 1 | 2015 | 578 | 0.100 |
Why?
|
Isoenzymes | 1 | 2016 | 1689 | 0.090 |
Why?
|
Genome, Human | 2 | 2015 | 4448 | 0.090 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2020 | 2880 | 0.090 |
Why?
|
Protein Structure, Tertiary | 2 | 2015 | 3750 | 0.090 |
Why?
|
Recurrence | 2 | 2021 | 8501 | 0.090 |
Why?
|
Repressor Proteins | 1 | 2021 | 2968 | 0.080 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2018 | 1534 | 0.080 |
Why?
|
Recombinant Fusion Proteins | 1 | 2018 | 3737 | 0.080 |
Why?
|
Cell Proliferation | 4 | 2021 | 10429 | 0.080 |
Why?
|
NF-kappa B | 1 | 2017 | 2485 | 0.080 |
Why?
|
Single-Cell Analysis | 1 | 2020 | 2535 | 0.080 |
Why?
|
Xenograft Model Antitumor Assays | 4 | 2019 | 3608 | 0.080 |
Why?
|
Forkhead Transcription Factors | 1 | 2016 | 1624 | 0.080 |
Why?
|
Peptides | 1 | 2020 | 4331 | 0.080 |
Why?
|
Aromatase Inhibitors | 1 | 2012 | 518 | 0.080 |
Why?
|
Mutagenesis | 1 | 2012 | 1228 | 0.080 |
Why?
|
Female | 20 | 2022 | 396112 | 0.080 |
Why?
|
Ovarian Neoplasms | 2 | 2016 | 4900 | 0.070 |
Why?
|
Neoplastic Stem Cells | 1 | 2016 | 1352 | 0.070 |
Why?
|
Nerve Tissue Proteins | 1 | 2020 | 4392 | 0.070 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2010 | 506 | 0.070 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2015 | 1608 | 0.070 |
Why?
|
Gene Silencing | 1 | 2013 | 1505 | 0.070 |
Why?
|
Translocation, Genetic | 1 | 2012 | 1394 | 0.070 |
Why?
|
Oncogenes | 1 | 2012 | 1235 | 0.070 |
Why?
|
Humans | 23 | 2022 | 765968 | 0.060 |
Why?
|
RNA, Messenger | 2 | 2018 | 12768 | 0.060 |
Why?
|
Neoplasm Metastasis | 3 | 2021 | 4893 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2020 | 9373 | 0.060 |
Why?
|
Neoplasm Proteins | 1 | 2016 | 3596 | 0.060 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2012 | 2844 | 0.050 |
Why?
|
Prognosis | 5 | 2022 | 29922 | 0.050 |
Why?
|
Obesity, Morbid | 1 | 2013 | 1292 | 0.050 |
Why?
|
RecQ Helicases | 1 | 2022 | 54 | 0.050 |
Why?
|
Cisplatin | 2 | 2022 | 1658 | 0.050 |
Why?
|
Active Transport, Cell Nucleus | 2 | 2016 | 431 | 0.050 |
Why?
|
Cell Cycle Proteins | 1 | 2013 | 3430 | 0.050 |
Why?
|
Cell Nucleus | 1 | 2010 | 2867 | 0.050 |
Why?
|
Tumor Cells, Cultured | 2 | 2020 | 6113 | 0.050 |
Why?
|
Software | 1 | 2015 | 4462 | 0.050 |
Why?
|
Mice, Nude | 2 | 2017 | 3618 | 0.040 |
Why?
|
Antigens, CD | 2 | 2021 | 4025 | 0.040 |
Why?
|
Genomic Instability | 1 | 2022 | 718 | 0.040 |
Why?
|
Proto-Oncogene Proteins | 1 | 2010 | 4520 | 0.040 |
Why?
|
Lysine | 1 | 2022 | 991 | 0.040 |
Why?
|
Recombination, Genetic | 1 | 2022 | 1525 | 0.040 |
Why?
|
Acrylates | 1 | 2016 | 75 | 0.030 |
Why?
|
Tamoxifen | 1 | 2021 | 963 | 0.030 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2022 | 1314 | 0.030 |
Why?
|
Organoids | 1 | 2022 | 739 | 0.030 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2021 | 752 | 0.030 |
Why?
|
Chick Embryo | 1 | 2017 | 964 | 0.030 |
Why?
|
Platinum | 1 | 2016 | 218 | 0.030 |
Why?
|
Algorithms | 1 | 2015 | 14071 | 0.030 |
Why?
|
Hydrazines | 1 | 2016 | 223 | 0.030 |
Why?
|
Immunoconjugates | 1 | 2022 | 981 | 0.030 |
Why?
|
Cohort Studies | 1 | 2017 | 41649 | 0.030 |
Why?
|
Receptors, Estrogen | 1 | 2022 | 2242 | 0.030 |
Why?
|
Survival Rate | 2 | 2019 | 12795 | 0.030 |
Why?
|
Gene Order | 1 | 2013 | 164 | 0.030 |
Why?
|
Physical Chromosome Mapping | 1 | 2013 | 183 | 0.030 |
Why?
|
Mice | 5 | 2019 | 81819 | 0.030 |
Why?
|
Eye Proteins | 1 | 2016 | 628 | 0.030 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2014 | 220 | 0.020 |
Why?
|
Consanguinity | 1 | 2013 | 460 | 0.020 |
Why?
|
Saccharomyces cerevisiae | 1 | 2022 | 2674 | 0.020 |
Why?
|
CA-125 Antigen | 1 | 2014 | 283 | 0.020 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2014 | 720 | 0.020 |
Why?
|
Animals | 6 | 2020 | 168764 | 0.020 |
Why?
|
Apoptosis | 2 | 2017 | 9514 | 0.020 |
Why?
|
Triazoles | 1 | 2016 | 897 | 0.020 |
Why?
|
Nuclear Export Signals | 1 | 2010 | 8 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2014 | 13648 | 0.020 |
Why?
|
Nuclear Localization Signals | 1 | 2010 | 79 | 0.020 |
Why?
|
Glucose Tolerance Test | 1 | 2013 | 1180 | 0.020 |
Why?
|
Amino Acid Sequence | 2 | 2013 | 13400 | 0.020 |
Why?
|
Alternative Splicing | 1 | 2015 | 1107 | 0.020 |
Why?
|
Conserved Sequence | 1 | 2013 | 1160 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2021 | 6832 | 0.020 |
Why?
|
Gene Targeting | 1 | 2013 | 841 | 0.020 |
Why?
|
Phenotype | 2 | 2021 | 16721 | 0.020 |
Why?
|
Molecular Sequence Data | 2 | 2013 | 17594 | 0.020 |
Why?
|
Half-Life | 1 | 2010 | 644 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2020 | 2822 | 0.020 |
Why?
|
DNA | 1 | 2022 | 7202 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2017 | 3421 | 0.020 |
Why?
|
Protein Stability | 1 | 2010 | 577 | 0.020 |
Why?
|
Cell Line, Tumor | 2 | 2016 | 17075 | 0.020 |
Why?
|
Adult | 3 | 2019 | 223044 | 0.020 |
Why?
|
Genetic Linkage | 1 | 2013 | 2341 | 0.020 |
Why?
|
Cloning, Molecular | 1 | 2013 | 4165 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2016 | 3602 | 0.020 |
Why?
|
Neovascularization, Pathologic | 1 | 2017 | 2631 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2019 | 39193 | 0.020 |
Why?
|
Cell Survival | 1 | 2016 | 5747 | 0.020 |
Why?
|
Middle Aged | 2 | 2019 | 223009 | 0.020 |
Why?
|
Pedigree | 1 | 2013 | 4526 | 0.020 |
Why?
|
Cell Movement | 1 | 2017 | 5194 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2018 | 3655 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2013 | 2741 | 0.010 |
Why?
|
Signal Transduction | 2 | 2018 | 23601 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2019 | 14751 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2019 | 22223 | 0.010 |
Why?
|
Insulin Resistance | 1 | 2013 | 3985 | 0.010 |
Why?
|
Insulin | 1 | 2013 | 6599 | 0.010 |
Why?
|
Genotype | 1 | 2013 | 13024 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2013 | 14448 | 0.010 |
Why?
|
Cell Line | 1 | 2010 | 15543 | 0.010 |
Why?
|
Transcription Factors | 1 | 2016 | 12131 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2013 | 18293 | 0.010 |
Why?
|
Young Adult | 1 | 2013 | 59889 | 0.000 |
Why?
|
Neoplasms | 1 | 2015 | 22340 | 0.000 |
Why?
|
Male | 1 | 2013 | 363698 | 0.000 |
Why?
|